Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

US stock market report – Moderna jumps 17% on Australian vaccine approval

US stock markets broke their positive run with the Dow Jones and S&P 500 falling 0.3% and 0.9%, respectively, as commodity markets continue to digest the impacts of the Delta variant.

Both the energy and real estate sectors were among the hardest hit as the Chinese government’s policy of seeking to eliminate COVID-19 has sent growth expectations for the economy lower following the latest Wuhan outbreak.

Gold in flash crash, UN panel releases climate change report

Gold bullion was also hit as another Federal Reserve official warned that the tapering of bond purchases lies ahead in the coming months. It hit its lowest point since March, yet little has changed on the difficult outlook for the global economy.

The UN International Panel on Climate Change also released their latest report, suggesting that it is ‘unequivocal’ that humans have had an impact on the climate and predicting that weather disruptions will continue to increase in regularity.

Moderna shares surge

The Nasdaq was the standout, adding 0.2%, as shares in Moderna (NASDAQ: MRNA) surged over 17% following the approval for use of its COVID-19 vaccine here in Australia.

Featured podcast: Healthcare vs. Biotech & the CURE ETF

US stock market movers

Here’s how other popular US shares started the week on Monday.

Back home on the ASX, the S&P/ASX 200 (ASX: XJO) is set to open higher on Tuesday. Check out Rask Media’s daily ASX 200 morning report for all the latest.

The Golden Rules of Investing

We might be experts in retirement, but with combined financial advice experience of 35+ years, we’ve nearly seen it all. 

In mid-2023, our senior team at Wattle Partners Financial Planning put the finishing touches on a brand-new report “The Golden Rules of Investing“.

In this free report, we outline the key principles that determine all of the portfolio construction and investment decisions of Wattle Partners. Collated over decades, this paper should be seen as a work-in-progress, constantly under review in light of the ever-evolving nature of markets. 

You’ll find the free report on my Author page. Simply click the button below to view the Golden Rules.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.


Disclosure: At the time of publishing, Drew owns shares in Trade Desk.

Powered by

Wattle Partners is a financial advice firm, servicing clients around Australia, specialising in retirement planning (pre and post retirement). 

Skip to content